Fibrinolytic and defibrinating effect of phenformin plus ethyloestrenol in vivo.
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001777:Blood Coagulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D005032:Ethylestrenol / Q000008:administration & dosage*; D005260:Female; D005337:Fibrin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010629:Phenformin / Q000008:administration & dosage*; D010919:Placebos; D013997:Time Factors; D014652:Vascular Diseases / Q000517:prevention & control
D010919:Placebos; D005337:Fibrin; D005340:Fibrinogen; D005032:Ethylestrenol; D010629:Phenformin